Sanger, Illumina Team Sequences Tasmanian Devil Genome | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Researchers from the Wellcome Trust Sanger Institute and Illumina announced that they have sequenced a draft version of the Tasmanian devil genome as well as a pair of cancer genomes from animals with Tasmanian devil facial tumor disease, a transmissible cancer plaguing wild devils.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.